Search Results - "Pots, Jeanette"
-
1
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Published in Clinical cancer research (01-05-2016)“…Thus far, dendritic cell (DC)-based immunotherapy of cancer was primarily based on in vitro-generated monocyte-derived DCs, which require extensive in vitro…”
Get full text
Journal Article -
2
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Published in Biomaterials (01-06-2012)“…Abstract Vaccine efficacy is improved upon specific delivery to professional antigen (Ag) presenting cells, such as dendritic cells (DCs). Antigenicity and…”
Get full text
Journal Article -
3
Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy
Published in Methods in cell biology (2024)“…Dendritic cell (DC) vaccination is a promising approach to induce tumor-specific immune responses in cancer patients. Until recently, most DC vaccines were…”
Get full text
Journal Article -
4
Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing
Published in Pharmaceutics (01-08-2022)“…Poly(lactic-co-glycolic acid) (PLGA) nanoparticle-based drug delivery systems are known to offer a plethora of potential therapeutic benefits. However,…”
Get full text
Journal Article -
5
Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer
Published in European journal of cancer (1990) (01-08-2011)“…Abstract Epithelial ovarian cancer (EOC) is an immunogenic tumour and exploits many suppressive ways to escape immune eradication. EOC is known to spread…”
Get full text
Journal Article -
6
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
Published in Oncoimmunology (03-08-2015)“…Autologous dendritic cell (DC) therapy is an experimental cellular immunotherapy that is safe and immunogenic in patients with advanced melanoma. In an attempt…”
Get full text
Journal Article -
7
Successful generation of primary virus-specific and anti-tumor T-cell responses from the naïve donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells
Published in Haematologica (Roma) (01-08-2011)“…One of the major challenges in allogeneic stem cell transplantation is to find a balance between the harmful induction of graft-versus-host disease and the…”
Get full text
Journal Article -
8
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome
Published in BMC immunology (17-12-2012)“…Chronic fatigue syndrome (CFS) is a clinical condition characterized by severe and disabling fatigue that is medically unexplained and lasts longer than 6…”
Get full text
Journal Article -
9
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue
Published in Human vaccines & immunotherapeutics (03-07-2015)“…The aim of this study was to compare humoral and cellular immune responses to influenza vaccination in cancer survivors with and without severe symptoms of…”
Get full text
Journal Article -
10
Sequence Analysis of the Structural Nuclear Encoded Subunits and Assembly Genes of Cytochrome c Oxidase in a Cohort of 10 Isolated Complex IV—Deficient Patients Revealed Five Mutations
Published in Journal of child neurology (01-06-2006)“…The mitochondrial oxidative phosphorylation system is composed of five multiprotein complexes. The fourth complex of this system, cytochrome c oxidase (complex…”
Get full text
Journal Article -
11
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Published in Cancer Immunology, Immunotherapy (01-03-2016)“…Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and…”
Get full text
Journal Article -
12
Both the Activation Kinetics and the Frequency of Regulatory T Cells Determine the Ability to Generate Primary Anti-Tumor and Pathogen- Specific Immune Responses from a Naïve Donor T Cell Repertoire
Published in Blood (16-11-2008)“…Allogeneic stem cell transplantation (allo-SCT) is commonly used in the treatment of patients with hematological malignancies. However, the impaired immune…”
Get full text
Journal Article -
13
Both the Activation Kinetics and the Frequency of Regulatory T Cells Determine the Ability to Generate Primary Anti-Tumor and Pathogen- Specific Immune Responses from a Naïve Donor T Cell Repertoire
Published in Blood (16-11-2008)“…Abstract Allogeneic stem cell transplantation (allo-SCT) is commonly used in the treatment of patients with hematological malignancies. However, the impaired…”
Get full text
Journal Article -
14
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor
Published in International journal of gynecological cancer (01-10-2011)“…Ovarian tumors, both benign and malignant, often contain cystic lesions. Analysis of cytokine levels of this enclosed fluid may be a pure way to study cytokine…”
Get more information
Journal Article